Last verified · v1.0

Calculator · health

Fresh Frozen Plasma (Ffp) Dose Calculator

Calculate FFP transfusion dose in mL or units based on patient weight (10-20 mL/kg). Adjust for clinical indication: coagulopathy, warfarin reversal, or massive transfusion.

FreeInstantNo signupOpen source

Inputs

Patient Weight

Base Dose per kg

Clinical Indication

Output Format

Total FFP Dose

—

Get a plain-English breakdown of your result with practical next steps.

Total FFP Dose—mL

The formula

How the
result is
computed.

Fresh Frozen Plasma Dose Calculator: Methodology and Clinical Guide

Fresh frozen plasma (FFP) is a blood product derived from whole blood or apheresis that contains all coagulation factors, including the labile factors V and VIII, fibrinogen, and von Willebrand factor. Clinicians use FFP to treat coagulopathies, reverse anticoagulation, and manage massive hemorrhage. The fresh frozen plasma dose calculator applies a straightforward weight-based formula to determine the required transfusion volume. FFP is particularly valuable because it provides a comprehensive spectrum of clotting factors in physiologic ratios, making it essential for managing complex bleeding disorders where specific factor concentrates are unavailable or inadequate.

Core Formula

The FFP dosing formula is:

V_FFP = W × D

V_FFP — Total FFP volume required (mL)
W — Patient body weight (kg)
D — Dose per kilogram (mL/kg), typically 10–20 mL/kg

According to StatPearls (NCBI Bookshelf), the standard FFP dose ranges from 10 to 20 mL/kg, with 15 mL/kg serving as the most commonly used starting point for most adult indications. To convert total volume to FFP units, divide V_FFP by 250 mL, since each standard unit contains approximately 200–250 mL of plasma. This unit-based conversion is critical for blood bank ordering and inventory management in acute care settings.

Coagulation Factor Considerations

Each milliliter of FFP contains approximately 1 unit of each coagulation factor at the time of collection. When administering 15 mL/kg FFP, the patient receives approximately 15 units/kg of factors II, V, VII, VIII, IX, X, XI, XII, and fibrinogen. This explains why higher doses are necessary for anticoagulant reversal (where rapid achievement of 30–50% factor activity is required) and why lower prophylactic doses may suffice in less acute scenarios. The plasma volume expansion also contributes to hemodynamic stability during massive hemorrhage management.

Clinical Indications and Dose Adjustments

The clinical indication significantly influences the dose selected within the 10–20 mL/kg range:

Coagulopathy / Active Bleeding: 15 mL/kg is the standard starting dose for most presentations of acquired coagulopathy.
Warfarin Reversal / Anticoagulant Reversal: A higher dose of 20 mL/kg is recommended when rapid correction of elevated INR is needed, as outlined in the UAMS Guidelines for Reversal of Anticoagulants.
Massive Transfusion Protocol (MTP): FFP is administered in a 1:1:1 ratio with packed red blood cells and platelets. A conservative 10 mL/kg is applied here because the protocol structure provides additional plasma.
Liver Disease / Surgical Prophylaxis: 10 mL/kg is appropriate when the objective is prophylactic factor replacement rather than acute hemorrhage control.
TTP / HUS: These conditions require therapeutic plasma exchange; specific dose requirements vary and are managed by specialist protocols.

Worked Examples

Example 1: Adult Patient with Coagulopathy

A 70 kg patient presents with active bleeding and an elevated INR. Using the standard 15 mL/kg dose:

V_FFP = 70 kg × 15 mL/kg = 1,050 mL

Dividing by 250 mL per unit: 1,050 ÷ 250 = 4.2 units → round up to 5 units of FFP.

Example 2: Warfarin Reversal

An 85 kg patient requires urgent warfarin reversal before emergency surgery. Using 20 mL/kg:

V_FFP = 85 kg × 20 mL/kg = 1,700 mL

Units required: 1,700 ÷ 250 = 6.8 units → round up to 7 units.

Mathematical Basis

The linear weight-based dosing model is validated by published mathematical modeling of FFP transfusion strategies (PMC3211733), which demonstrates that plasma volume replacement scales proportionally with body weight when targeting specific coagulation factor activity levels. This supports predictable factor recovery across patient sizes, provided the mL/kg dose is matched to the severity of the coagulopathy and the desired post-transfusion factor activity (typically ≥30% of normal for surgical hemostasis). The model assumes adequate mixing of transfused plasma with circulating blood and accounts for ongoing consumption and clearance of coagulation factors during active bleeding.

Clinical Limitations and Monitoring

The weight-based formula provides an initial dose estimate only. Actual requirements depend on baseline coagulation studies (PT, INR, aPTT, fibrinogen), ongoing blood loss, and reassessment after each transfusion. Recheck coagulation parameters approximately 1 hour after FFP infusion and adjust accordingly. FFP is not appropriate as a volume expander, for isolated hereditary factor deficiencies where specific concentrates are available, or as a nutritional supplement. Clinical judgment must always override the calculator when patient-specific factors warrant modification of the standard dosing approach.

Reference

Frequently asked questions

What is the standard FFP dose per kilogram of body weight?

The standard FFP dose is 10 to 20 mL per kilogram of body weight. Most clinical guidelines recommend 15 mL/kg as the typical starting dose for general coagulopathy or active bleeding. Higher doses of 20 mL/kg are used for urgent anticoagulant reversal, while 10 mL/kg is reserved for prophylactic use or massive transfusion protocol settings where the structured ratio provides additional plasma volume.

How many FFP units does a 70 kg patient typically require?

For a 70 kg patient receiving the standard 15 mL/kg dose, the total volume is 70 x 15 = 1,050 mL. Since each FFP unit contains approximately 250 mL, this equals 4.2 units, rounded up to 5 units for blood bank ordering purposes. At a higher dose of 20 mL/kg, the volume becomes 1,400 mL, requiring 6 units of FFP.

What are the accepted clinical indications for FFP transfusion?

Accepted indications include acquired coagulopathy with active bleeding or before high-risk invasive procedures, urgent reversal of vitamin K antagonists such as warfarin when prothrombin complex concentrate is unavailable, massive transfusion protocols, disseminated intravascular coagulation (DIC), and therapeutic plasma exchange for thrombotic thrombocytopenic purpura (TTP). FFP is not indicated for volume expansion alone or to correct hypoalbuminemia.

How does the clinical indication change the FFP dose used in the calculator?

Different indications call for different doses within the 10-20 mL/kg range. Warfarin reversal uses the maximum 20 mL/kg for rapid INR correction. Massive transfusion protocols apply 10 mL/kg because the 1:1:1 ratio with red cells and platelets supplies additional plasma volume. General coagulopathy defaults to 15 mL/kg, while surgical prophylaxis in liver disease also starts at 10 mL/kg to minimize circulatory overload risk.

What is the difference between displaying FFP dose in mL versus FFP units?

Displaying results in milliliters shows the precise infusion volume required, useful for fluid management calculations and nursing administration records. Displaying in units reflects how blood banks stock and issue the product, with one standard unit equaling approximately 250 mL. For example, 1,050 mL corresponds to 4.2 units; in practice the blood bank issues 5 units totaling 1,250 mL. Clinicians typically order by units while tracking exact volume separately.

When should FFP transfusion be avoided or replaced with another therapy?

FFP is contraindicated as a volume expander, for isolated hereditary factor deficiencies where specific factor concentrates are available, and as a nutritional supplement. For urgent warfarin reversal, prothrombin complex concentrate (PCC) is now the preferred first-line agent, correcting INR more rapidly with substantially less infused volume. Patients with a prior history of transfusion-associated acute lung injury (TRALI) related to FFP require careful risk-benefit reassessment before repeat exposure.